{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:05Z","timestamp":1792300265799,"version":"4.4.0"},"reference-count":432,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,4,1]]},"DOI":"10.1210\/er.2001-0025","type":"journal-article","created":{"date-parts":[[2003,4,16]],"date-time":"2003-04-16T20:53:49Z","timestamp":1050526429000},"page":"183-217","source":"Crossref","is-referenced-by-count":464,"title":["Androgens and Coronary Artery Disease"],"prefix":"10.1210","volume":"24","author":[{"given":"Fredrick C. W.","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Endocrinology (F.C.W.W.), Manchester Royal Infirmary, University of Manchester, Manchester M13 9WL, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry (A.v.E.), University of Zurich and University Hospital of Zurich, CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2019041121494346000_R1","first-page":"3","article-title":"Clinical review 85: emerging issues in androgen replacement therapy.","volume":"82","author":"Bhasin","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R2","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/jcem.84.6.5802","article-title":"Androgen replacement in women: a commentary.","volume":"84","author":"Davies","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020.","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat Med"},{"key":"2019041121494346000_R4","first-page":"383","article-title":"Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.","volume":"111","author":"Lerner","year":"1986","journal-title":"Am J Cardiol"},{"key":"2019041121494346000_R5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","article-title":"Lifetime risk of developing coronary heart disease.","volume":"353","author":"Lloyd-Jones","year":"1999","journal-title":"Lancet"},{"key":"2019041121494346000_R6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0039-128X(90)90058-J","article-title":"Sex hormones and coronary disease: a review of the clinical studies.","volume":"55","author":"Kalin","year":"1990","journal-title":"Steroids"},{"key":"2019041121494346000_R7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.ATV.19.8.1819","article-title":"Coronary heart disease: reducing the risk. The scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease.","volume":"19","author":"Assmann","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(00)02496-X","article-title":"Search for answers to ethnic disparities in cardiovascular risk.","volume":"356","author":"Levy","year":"2000","journal-title":"Lancet"},{"key":"2019041121494346000_R9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.95.1.252","article-title":"Sex difference in coronary heart disease.","volume":"95","author":"Barrett-Connor","year":"1997","journal-title":"Circulation"},{"key":"2019041121494346000_R10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease.","volume":"342","author":"Kohler","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0008-6363(00)00005-5","article-title":"The roles of gender, the menopause and hormone replacement on cardiovascular function.","volume":"46","author":"Hayward","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2019041121494346000_R12","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.89.23.11259","article-title":"Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.","volume":"89","author":"Hayashi","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121494346000_R13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/cs0970019","article-title":"Gender differences in endothelial regulation of 2-adrenoceptor-mediated contraction in the rat aorta.","volume":"97","author":"Tejera","year":"1999","journal-title":"Clin Sci"},{"key":"2019041121494346000_R14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.101.3.224","article-title":"Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis.","volume":"101","author":"McCrohon","year":"2000","journal-title":"Circulation"},{"key":"2019041121494346000_R15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/ajcn\/58.4.463","article-title":"Sex differences in the relation of visceral adipose tissue accumulation total body fatness.","volume":"58","author":"Lemieux","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"2019041121494346000_R16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(96)05864-9","article-title":"The relationship of natural androgens to coronary heart disease in males: a review.","volume":"125","author":"Alexandersen","year":"1996","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/eje.0.1440183","article-title":"Testosterone levels in healthy men and their relation to behavioural and physical characteristics: facts and constructs.","volume":"144","author":"Zitzmann","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2019041121494346000_R18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-56-6-1278","article-title":"A loss of circadian rhythmicity in blood testosterone levels with aging in normal men.","volume":"56","author":"Bremner","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men.","volume":"86","author":"Harman","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R20","first-page":"1","article-title":"Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.","volume":"12","author":"Mendoza","year":"1983","journal-title":"Artery"},{"key":"2019041121494346000_R21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0021-9150(83)90041-2","article-title":"Post heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis.","volume":"48","author":"Barth","year":"1983","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/BF01739675","article-title":"Concentration of lipid, apoprotein-B and testosterone in patients with coronarographic findings.","volume":"63","author":"Hromadova","year":"1985","journal-title":"Klin Wochenschr"},{"key":"2019041121494346000_R23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(85)92313-X","article-title":"Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease.","volume":"1","author":"Breier","year":"1985","journal-title":"Lancet"},{"key":"2019041121494346000_R24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1536\/ihj.27.825","article-title":"The determination of serum estradiol, testosterone and progesterone in acute myocardial infarction.","volume":"27","author":"Aksut","year":"1986","journal-title":"Jpn Heart J"},{"key":"2019041121494346000_R25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.ATV.6.4.418","article-title":"Sex hormone levels in young Indian patients with myocardial infarction.","volume":"6","author":"Sewdarsen","year":"1986","journal-title":"Arteriosclerosis"},{"key":"2019041121494346000_R26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0002-9343(87)90642-5","article-title":"Sex hormones and coronary artery disease.","volume":"83","author":"Chute","year":"1987","journal-title":"Am J Med"},{"key":"2019041121494346000_R27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0021-9150(87)90275-9","article-title":"Serum lipoproteins, sex hormones and sex hormone binding globulin in middle-aged men of different physical fitness and risk of coronary heart disease.","volume":"67","author":"Ha\u0308ma\u0308la\u0308inen","year":"1987","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/oxfordjournals.aje.a114704","article-title":"Sex hormones, insulin, lipids, and prevalent ischemic heart disease.","volume":"126","author":"Lichtenstein","year":"1987","journal-title":"Am J Epidemiol"},{"key":"2019041121494346000_R29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1532-5415.1987.tb01317.x","article-title":"Low serum testosterone and myocardial infarction in geriatric male inpatients.","volume":"35","author":"Swartz","year":"1987","journal-title":"J Am Geriatr Soc"},{"key":"2019041121494346000_R30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/pgmj.64.750.264","article-title":"The low plasma testosterone levels of young Indian infarct survivors are not due to a primary testicular defect.","volume":"64","author":"Sewdarsen","year":"1988","journal-title":"Postgrad Med J"},{"key":"2019041121494346000_R31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0021-9150(90)90156-D","article-title":"Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men.","volume":"83","author":"Sewdarsen","year":"1990","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ajmg.1320470421","article-title":"Cincinnati myocardial infarction and hormone family study: family resemblance for testosterone in random and MI families.","volume":"47","author":"Rice","year":"1993","journal-title":"Am J Med Genet"},{"key":"2019041121494346000_R33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.ATV.14.5.701","article-title":"The association of hypotestosteronemia with coronary artery disease in men.","volume":"14","author":"Phillips","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-5273(97)00295-7","article-title":"The association of low plasma testosterone level with coronary artery disease in Chinese men.","volume":"63","author":"Zhao","year":"1998","journal-title":"Int J Cardiol"},{"key":"2019041121494346000_R35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/euhj.1999.1873","article-title":"Men with coronary disease have lower levels of androgens than those with coronary angiograms.","volume":"21","author":"English","year":"2000","journal-title":"Eur Heart J"},{"key":"2019041121494346000_R36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archinte.1982.00340140044011","article-title":"Relationship between sex hormones, myocardial infarction, and occlusive coronary disease.","volume":"142","author":"Luria","year":"1982","journal-title":"Arch Intern Med"},{"key":"2019041121494346000_R37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000173490","article-title":"Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis.","volume":"69","author":"Labropoulos","year":"1982","journal-title":"Cardiology"},{"key":"2019041121494346000_R38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.2.1.58","article-title":"Abnormal hormone levels in men with coronary artery disease.","volume":"2","author":"Zumoff","year":"1982","journal-title":"Arteriosclerosis"},{"key":"2019041121494346000_R39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0002-9343(83)91078-1","article-title":"Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort.","volume":"74","author":"Phillips","year":"1983","journal-title":"Am J Med"},{"key":"2019041121494346000_R40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/acta.0.1040253","article-title":"Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin.","volume":"104","author":"Heller","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121494346000_R41","first-page":"775","article-title":"Serum oestradiol and ischaemic heart disease relationship with myocardial infarction but not coronary atheroma or haemostasis.","volume":"57","author":"Small","year":"1985","journal-title":"Q J Med"},{"key":"2019041121494346000_R42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0021-9150(86)90030-4","article-title":"Low serum apolipoprotein A-1 in acute myocardial infarction survivors with normal HDL cholesterol.","volume":"59","author":"Franzen","year":"1986","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0002-9149(87)91021-6","article-title":"Usefulness of sex steroid hormone levels in predicting coronary artery disease in men.","volume":"60","author":"Cauley","year":"1987","journal-title":"Am J Cardiol"},{"key":"2019041121494346000_R44","first-page":"449","article-title":"Plasma estrogens, androgens, and von Willebrand factor in men on chronic hemodialysis.","volume":"11","author":"Baumann","year":"1988","journal-title":"Int J Artif Organs"},{"key":"2019041121494346000_R45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.CIR.78.3.539","article-title":"Endogenous sex hormones and cardiovascular disease in men. A prospective population based study.","volume":"78","author":"Barrett-Connor","year":"1988","journal-title":"Circulation"},{"key":"2019041121494346000_R46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0895-4356(88)90018-2","article-title":"Serum sex hormone levels and myocardial infarction in the Honolulu Heart Program. Pitfalls in prospective studies on sex hormones.","volume":"41","author":"Phillips","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"2019041121494346000_R47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0021-9150(89)90124-X","article-title":"Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction.","volume":"79","author":"Slowinska-Srzednicka","year":"1989","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/j.1939-4640.1990.tb00178.x","article-title":"Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men.","volume":"11","author":"Contoreggi","year":"1990","journal-title":"J Androl"},{"key":"2019041121494346000_R49","first-page":"195","article-title":"Serum creatinine phosphokinase, lactic dehydrogenase, estradiol, progesterone, and testosterone levels in male patients with acute myocardial infarction and unstable angina pectoris.","volume":"23","author":"Cengiz","year":"1991","journal-title":"Mater Med Pol"},{"key":"2019041121494346000_R50","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/BF01649428","article-title":"Sex hormone concentration in men with angiographically assessed coronary artery disease\u2014relationship to obesity and body fat distribution.","volume":"69","author":"Hauner","year":"1991","journal-title":"Klin Wochenschr"},{"key":"2019041121494346000_R51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.ATV.13.4.517","article-title":"Endogenous sex hormones and ischaemic heart disease in men. The Caerphilly prospective study.","volume":"13","author":"Yarnell","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"2019041121494346000_R52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9150(94)90049-3","article-title":"Adrenal androgens and testosterone as coronary risk factors in the Helsinki heart study.","volume":"105","author":"Hautenen","year":"1994","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.89.1.89","article-title":"Evidence for an association between dehydroepiandrosterone sulfate and non-fatal, premature myocardial infarction in males.","volume":"89","author":"Mitchell","year":"1994","journal-title":"Circulation"},{"key":"2019041121494346000_R54","first-page":"1794","article-title":"Relationships of plasminogen activator inhibitor activity and lipoprotein (a) with insulin, testosterone, 17\u03b2-estradiol, and testosterone binding globulin in myocardial infarction patients and healthy controls.","volume":"80","author":"Marquez-Vidal","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1047-2797(97)00199-3","article-title":"Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts male aging study.","volume":"8","author":"Feldman","year":"1998","journal-title":"Ann Epidemiol"},{"key":"2019041121494346000_R56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000006977","article-title":"Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography.","volume":"92","author":"Kabakci","year":"1999","journal-title":"Cardiology"},{"key":"2019041121494346000_R57","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.ATV.20.4.e10","article-title":"Insulin-like growth factor binding protein-3 is associated with the presence and extent of coronary arteriosclerosis.","volume":"20","author":"Schuler-Lu\u0308ttmann","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R58","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2000.7716a","article-title":"Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.","volume":"49","author":"Dobs","year":"2000","journal-title":"Metabolism"},{"key":"2019041121494346000_R59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.311.7014.1193","article-title":"Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women.","volume":"311","author":"Barrett-Connor","year":"1995","journal-title":"Br Med J"},{"key":"2019041121494346000_R60","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.ATV.17.4.695","article-title":"Relationship between serum sex hormones and coronary artery disease in postmenopausal women.","volume":"17","author":"Phillips","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R61","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jcem.84.6.5824","article-title":"Endogenous androgens and carotid intimal-medial thickness in women.","volume":"84","author":"Bernini","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R62","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular disease risk and androgen excess.","volume":"98(Suppl 1A)","author":"Wild","year":"1995","journal-title":"Am J Med"},{"key":"2019041121494346000_R63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0950-351X(96)80155-8","article-title":"Cardiovascular disease and diabetes in women with polycystic ovary syndrome.","volume":"10","author":"McKeigue","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"2019041121494346000_R64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2007-1016293","article-title":"Metabolic aspects of polycystic ovary syndrome.","volume":"15","author":"Wild","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"2019041121494346000_R65","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121494346000_R66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0889-8529(05)70079-7","article-title":"Cardiovascular consequences of polycystic ovary syndrome.","volume":"28","author":"Amowitz","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121494346000_R67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1525-1381.1999.99231.x","article-title":"The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.","volume":"111","author":"Sobel","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"2019041121494346000_R68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.2000.tb11572.x","article-title":"Polycystic ovary syndrome: a risk factor for cardiovascular disease?","volume":"107","author":"Rajkhowa","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041121494346000_R69","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-132-12-200006200-00010","article-title":"The importance of diagnosing the polycystic ovary syndrome.","volume":"132","author":"Lobo","year":"2000","journal-title":"Ann Intern Med"},{"key":"2019041121494346000_R70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0889-8545(05)70189-3","article-title":"Cardiovascular risk in women with polycystic ovarian syndrome.","volume":"28","author":"Tabott","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2019041121494346000_R71","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Woman with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focussing on natural history and circulating hormones.","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)53699-1","article-title":"Clinical signs of androgen excess as risk factors fro coronary artery disease.","volume":"54","author":"Wild","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization.","volume":"126","author":"Birdsall","year":"1997","journal-title":"Ann Intern Med"},{"key":"2019041121494346000_R74","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121494346000_R75","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R76","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mullitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovarian syndrome.","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"2019041121494346000_R77","author":"Christian"},{"key":"2019041121494346000_R78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0015-0282(99)00468-9","article-title":"Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity.","volume":"73","author":"Mather","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R79","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up.","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019041121494346000_R80","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R81","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes, hypertension, and cardiac complaints in a follow-up study of a Dutch PCOS population.","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121494346000_R82","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/geronj\/24.4.395","article-title":"Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population.","volume":"24","author":"Hamilton","year":"1969","journal-title":"J Gerontol"},{"key":"2019041121494346000_R83","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/366215a0","article-title":"Lifespan and testosterone.","volume":"366","author":"Nieschlag","year":"1993","journal-title":"Nature"},{"key":"2019041121494346000_R84","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jcem.84.12.6206","article-title":"Long-term consequence of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts.","volume":"84","author":"Wilson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R85","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones.","volume":"47","author":"Van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/edrv-9-2-181","article-title":"Androgen abuse by athletes.","volume":"9","author":"Wilson","year":"1988","journal-title":"Endocr Rev"},{"key":"2019041121494346000_R87","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1001\/jama.1990.03450220089029","article-title":"Medical and Non-medical uses of anabolic-androgenic steroids.","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"2019041121494346000_R88","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jama.1993.03510100067034","article-title":"Anabolic-androgen steroid use in the United States.","volume":"270","author":"Yesalis","year":"1993","journal-title":"JAMA"},{"key":"2019041121494346000_R89","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.pa.33.040193.002433","article-title":"Cardiovascular toxicity of anabolic steroids.","volume":"33","author":"Rockhold","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2019041121494346000_R90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-0620(98)80019-4","article-title":"The cardiac toxicity of anabolic steroids.","volume":"41","author":"Sullivan","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"2019041121494346000_R91","first-page":"554","article-title":"Treatment of angina pectoris and coronary artery disease with sex hormones.","volume":"37","author":"Bonnel","year":"1941","journal-title":"Ohio State Med J"},{"key":"2019041121494346000_R92","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/jcem-2-5-325","article-title":"Testosterone propionate in the treatment of angina pectoris.","volume":"2","author":"Hamm","year":"1942","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R93","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-2-9-560","article-title":"Use of testosterone propionate and estrogenic substance in treatment of essential hypertension, angina pectoris, and peripheral vascular disease.","volume":"2","author":"Walker","year":"1942","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R94","first-page":"1424","article-title":"Treatment of angina pectoris with testosterone propionate.","volume":"43","author":"Sigler","year":"1943","journal-title":"NY State J Med"},{"key":"2019041121494346000_R95","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM194311182292102","article-title":"The therapeutic value of testosterone propionate in angina pectoris.","volume":"228","author":"Levine","year":"1943","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R96","first-page":"546","article-title":"The treatment of angina pectoris and essential hypertension by testosterone propionate.","volume":"12","author":"Opit","year":"1943","journal-title":"Med J Aust"},{"key":"2019041121494346000_R97","first-page":"137","article-title":"The treatment of angina pectoris by testosterone propionate.","volume":"14","author":"Opit","year":"1943","journal-title":"Med J Aust"},{"key":"2019041121494346000_R98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJM194201082260203","article-title":"The treatment of angina pectoris with testosterone propionate; preliminary report.","volume":"226","author":"Lesser","year":"1942","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R99","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM194302112280603","article-title":"The treatment of angina pectoris with testosterone propionate: further observations.","volume":"228","author":"Lesser","year":"1943","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R100","first-page":"30","article-title":"Treatment of angina pectoris and peripheral vascular disease with sex hormones.","volume":"50","author":"Strong","year":"1944","journal-title":"Can Med Assoc J"},{"key":"2019041121494346000_R101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/jcem-6-8-549","article-title":"Testosterone propionate therapy in one hundred cases of angina pectoris.","volume":"6","author":"Lesser","year":"1946","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R102","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9149(98)00880-7","article-title":"Effect of acute testosterone on myocardial ischemia in men with coronary artery disease.","volume":"83","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"key":"2019041121494346000_R103","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.100.16.1690","article-title":"Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.","volume":"100","author":"Webb","year":"1999","journal-title":"Circulation"},{"key":"2019041121494346000_R104","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.99.13.1666","article-title":"Acute anti-ischemic effect of testosterone in men with coronary artery disease.","volume":"99","author":"Rosano","year":"1999","journal-title":"Circulation"},{"key":"2019041121494346000_R105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/hrt.39.11.1217","article-title":"Effect of testosterone on postexercise ST segment depression.","volume":"39","author":"Jaffe","year":"1977","journal-title":"Br Heart J"},{"key":"2019041121494346000_R106","first-page":"415","article-title":"Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients.","volume":"106","author":"Wu","year":"1993","journal-title":"Chin Med J"},{"key":"2019041121494346000_R107","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.102.16.1906","article-title":"Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina.","volume":"102","author":"English","year":"2000","journal-title":"Circulation"},{"key":"2019041121494346000_R108","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jcem.86.3.7369","article-title":"Editorial: the role of androgens in women.","volume":"86","author":"Snyder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R109","first-page":"561","article-title":"Androgen deficiency in women with hypopituitarism.","volume":"86","author":"Miller","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9378(74)90490-6","article-title":"Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.","volume":"118","author":"Judd","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121494346000_R111","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00003081-197612000-00005","article-title":"Hormonal dynamics associated with the menopause.","volume":"19","author":"Judd","year":"1976","journal-title":"Clin Obstet Gynecol"},{"key":"2019041121494346000_R112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1043-2760(00)00333-7","article-title":"Testosterone influences libido and well being in women.","volume":"12","author":"Davis","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121494346000_R113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0021-9150(84)90143-6","article-title":"Ultrastructural changes in the comb and aorta of chicks fed excess testosterone.","volume":"51","author":"Toda","year":"1984","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0021-9150(93)90053-W","article-title":"Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels.","volume":"99","author":"Larsen","year":"1993","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/00365519009089189","article-title":"Stanozolol and experimental atherosclerosis: atherosclerosis development and blood lipids during anabolic steroid therapy of New Zealand white rabbits.","volume":"50","author":"Fogelberg","year":"1990","journal-title":"Scand J Clin Lab Invest"},{"key":"2019041121494346000_R116","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.ATV.15.5.562","article-title":"Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness.","volume":"15","author":"Adams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R117","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.CIR.93.3.577","article-title":"Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.","volume":"93","author":"Chen","year":"1996","journal-title":"Circulation"},{"key":"2019041121494346000_R118","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.ATV.17.10.2192","article-title":"Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits.","volume":"17","author":"Bruck","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R119","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.RES.84.7.813","article-title":"Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.","volume":"84","author":"Alexandersen","year":"1999","journal-title":"Circ Res"},{"key":"2019041121494346000_R120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0026-0495(96)90220-6","article-title":"Effects of the anabolic steroid nandrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques.","volume":"45","author":"Obasanjo","year":"1996","journal-title":"Metabolism"},{"key":"2019041121494346000_R121","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/01.ATV.17.11.2679","article-title":"17\u03b2-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice.","volume":"17","author":"Elhage","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R122","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2001-12405","article-title":"Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones.","volume":"33","author":"von Dehn","year":"2001","journal-title":"Horm Metab Res"},{"key":"2019041121494346000_R122A","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1073\/pnas.051003698","article-title":"Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase.","volume":"98","author":"Nathan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121494346000_R123","first-page":"156","article-title":"Testosterone and risk factors for cardiovascular disease in men.","volume":"21","author":"Barret-Connor","year":"1995","journal-title":"Diabetes Metab"},{"key":"2019041121494346000_R124","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/sj.ijo.0801280","article-title":"The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone.","volume":"24(Suppl 2)","author":"De Pergola","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121494346000_R125","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/0026-0495(89)90014-0","article-title":"Plasminogen activator inhibitor in plasma is related to testosterone in men.","volume":"38","author":"Caron","year":"1989","journal-title":"Metabolism"},{"key":"2019041121494346000_R126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/01.ATV.11.2.307","article-title":"Relation of serum testosterone levels to high density lipoprotein cholesterol and other characteristics in men.","volume":"11","author":"Freedman","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"2019041121494346000_R127","first-page":"412","article-title":"Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.","volume":"122","author":"Glueck","year":"1993","journal-title":"J Lab Clin Med"},{"key":"2019041121494346000_R128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0026-0495(86)90011-9","article-title":"Relationship of serum lipoproteins and apoproteins to the binding capacity of sex hormone binding globulin in healthy Finnish men.","volume":"35","author":"Ha\u0308ma\u0308la\u0308inen","year":"1986","journal-title":"Metabolism"},{"key":"2019041121494346000_R129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9343(89)80480-2","article-title":"Sex hormones and lipoproteins in men.","volume":"87","author":"Kiel","year":"1989","journal-title":"Am J Med"},{"key":"2019041121494346000_R130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.ATV.13.4.467","article-title":"Relation of hemostatic factors to other risk factors for coronary artery disease and to sex hormones in men.","volume":"13","author":"Yang","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"2019041121494346000_R131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(99)00027-1","article-title":"Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals.","volume":"145","author":"Hergenc","year":"1999","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R132","first-page":"S155","article-title":"Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.","volume":"150(Suppl)","author":"Tchernof","year":"1996","journal-title":"J Endocrinol"},{"key":"2019041121494346000_R133","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.ijo.0801183","article-title":"Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men.","volume":"24","author":"Tsai","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121494346000_R134","first-page":"682","article-title":"Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom study.","volume":"82","author":"Simon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R135","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0026-0495(90)90297-P","article-title":"Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels but negatively with testosterone levels.","volume":"39","author":"Seidell","year":"1990","journal-title":"Metabolism"},{"key":"2019041121494346000_R136","first-page":"1515","article-title":"Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy.","volume":"78","author":"Leenen","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R137","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1210\/jcem-53-4-828","article-title":"The effect of weight loss on reproductive hormones in obese men.","volume":"53","author":"Stanick","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R138","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1038\/sj.ijo.0801281","article-title":"Synthesis and regulation of sex hormone-binding globulin in obesity.","volume":"24(Suppl 2)","author":"Hautanen","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121494346000_R139","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/eje.0.1430085","article-title":"Sex hormone-binding globulin as a marker for hyperinsulinemia and\/or insulin resistance in obese children.","volume":"143","author":"Gascon","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"2019041121494346000_R140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0026-0495(97)90189-X","article-title":"Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men.","volume":"46","author":"Pasquali","year":"1997","journal-title":"Metabolism"},{"key":"2019041121494346000_R141","first-page":"291","article-title":"The regulation of adipose tissue distribution in humans.","volume":"20","author":"Bjo\u0308rntorp","year":"1996","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121494346000_R142","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0002-9343(99)80058-8","article-title":"Endogenous sex hormones: impact on lipds, lipoproteins, and insulin.","volume":"98(Suppl 1A)","author":"Haffner","year":"1995","journal-title":"Am J Med"},{"key":"2019041121494346000_R143","first-page":"239","article-title":"Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens.","volume":"80","author":"Marin","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R144","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/07853899608999068","article-title":"Decreased androgen levels and obesity in men.","volume":"28","author":"Vermeulen","year":"1996","journal-title":"Ann Med"},{"key":"2019041121494346000_R145","first-page":"1026","article-title":"Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroids hormone concentration in men: the HERITAGE family study.","volume":"85","author":"Couillard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R146","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2265.1997.2681067.x","article-title":"Strong association between serum levels of leptin and testosterone in men.","volume":"47","author":"Behre","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R147","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jcem.82.6.3988","article-title":"Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.","volume":"82","author":"Sih","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R148","first-page":"2839","article-title":"Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone gel study group.","volume":"85","author":"Wang","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"2019041121494346000_R149","first-page":"991","article-title":"The effects of testosterone treatment on body composition and metabolism in middle aged men.","volume":"16","author":"Marin","year":"1992","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121494346000_R150","first-page":"245","article-title":"Androgen treatment of abdominally obese men.","volume":"1","author":"Marin","year":"1993","journal-title":"Obesity Res Relat Metab Disord"},{"key":"2019041121494346000_R151","first-page":"791","article-title":"Effect of testosterone on abdominal adipose tissue in men.","volume":"15","author":"Rebuffe\u0301-Scrive","year":"1991","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121494346000_R152","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0029-1232561","article-title":"Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin.","volume":"107","author":"Bu\u0308chter","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2019041121494346000_R153","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2796.1993.tb01016.x","article-title":"Hyperandrogenicity in women\u2014a prediabetic condition?","volume":"234","author":"Bjo\u0308rntorp","year":"1993","journal-title":"J Intern Med"},{"key":"2019041121494346000_R154","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041433-199405030-00003","article-title":"Fatty acids, hyperinsulinemia, and insulin resistance: which comes first?","volume":"5","author":"Bjo\u0308rntorp","year":"1994","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/endo.141.2.7293","article-title":"Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2.","volume":"141","author":"Dieudonne","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121494346000_R156","first-page":"1687","article-title":"Leptin concentrations in the polycystic ovary syndrome.","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R157","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jcem.82.6.3996","article-title":"Serum leptin concentrations in women with polycystic ovary syndrome.","volume":"82","author":"Rouru","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R158","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0026-0495(98)90195-0","article-title":"Sex hormone-binding globulin and insulin resistance in African-American women.","volume":"47","author":"Sherif","year":"1998","journal-title":"Metabolism"},{"key":"2019041121494346000_R159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diab.40.1.123","article-title":"Low sex hormone binding globulin concentration as an independent risk factor for development of NIDDM: 12 yr follow up of population study of women in Gothenburg.","volume":"40","author":"Lindstedt","year":"1991","journal-title":"Diabetes"},{"key":"2019041121494346000_R160","first-page":"342","article-title":"Abnormalities of fuel metabolism in the polycystic ovary syndrome.","volume":"60","author":"Wortsman","year":"1982","journal-title":"Obstet Gynecol"},{"key":"2019041121494346000_R161","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0015-0282(16)48142-2","article-title":"Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk for coronary heart disease.","volume":"42","author":"Mattson","year":"1984","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R162","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovarian syndrome.","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R163","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R164","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women.","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041121494346000_R165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome.","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R166","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome.","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R167","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R168","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/09513599609012817","article-title":"Elevated low density lipoprotein -cholesterol in women with polycystic ovary syndrome.","volume":"10","author":"von Eckardstein","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"2019041121494346000_R169","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/09513599909167585","article-title":"Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.","volume":"13","author":"Fox","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"2019041121494346000_R170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0015-0282(98)00473-7","article-title":"Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.","volume":"71","author":"Penttila","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R171","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00006254-200005000-00026","article-title":"Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.","volume":"55","author":"Sozen","year":"2000","journal-title":"Obstet Gynecol Surv"},{"key":"2019041121494346000_R172","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.1993.tb00996.x","article-title":"Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.","volume":"38","author":"Conway","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R173","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease.","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R174","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-66-1-131","article-title":"The impact of obesity on chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.","volume":"66","author":"Dunaif","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1990.tb00472.x","article-title":"The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.","volume":"33","author":"Graf","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R176","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000184794","article-title":"Sex hormone-binding protein, hyperinsulinemia, insulin resistance and non-insulin-dependent diabetes.","volume":"45","author":"Haffner","year":"1996","journal-title":"Horm Res"},{"key":"2019041121494346000_R177","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1994.tb02577.x","article-title":"Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R178","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary.","volume":"28","author":"Franks","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121494346000_R179","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(99)00184-3","article-title":"Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.","volume":"72","author":"Acie\u0301n","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R180","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R181","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","article-title":"Current concepts in the polycystic ovarian syndrome.","volume":"52","author":"Dunaif","year":"2001","journal-title":"Annu Rev Med"},{"key":"2019041121494346000_R182","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R183","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor 1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.","volume":"46","author":"Velazquez","year":"1997","journal-title":"Metabolism"},{"key":"2019041121494346000_R184","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/eje.0.1380253","article-title":"Insulin sensitizing agents and polycystic ovary syndrome.","volume":"138","author":"Pasquali","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2019041121494346000_R185","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R186","first-page":"4278","article-title":"Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels.","volume":"84","author":"Lemieux","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R187","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","article-title":"Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.","volume":"13","author":"Dahlgren","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121494346000_R188","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.","volume":"81","author":"Morghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R189","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","article-title":"The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.","volume":"83","author":"Diamanti-Kandarakis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R190","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens.","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R191","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0026-0495(99)90146-4","article-title":"Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals.","volume":"48","author":"Elbers","year":"1999","journal-title":"Metabolism"},{"key":"2019041121494346000_R192","first-page":"2198","article-title":"Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women\u2014a clinical research center study.","volume":"81","author":"Lovejoy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R193","first-page":"4420","article-title":"Effects of methyltestosterone on insulin secretion and sensitivity in women.","volume":"83","author":"Diamond","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R194","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI1353","article-title":"Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats.","volume":"101","author":"Nilsson","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R195","first-page":"1206","article-title":"Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys.","volume":"85","author":"Eisner","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R196","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome.","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121494346000_R197","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome.","volume":"340","author":"Nestler","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R198","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1002\/j.1550-8528.1998.tb00683.x","article-title":"The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients\u2019 risk.","volume":"6(Suppl 1)","author":"Despre\u0301s","year":"1998","journal-title":"Obes Res"},{"key":"2019041121494346000_R199","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Diabetic dyslipidemia: causes and consequences.","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R200","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.1987.03390040118029","article-title":"Decrease in plasma high density lipoprotein cholesterol levels at puberty in boys with delayed adolescence: correlation with plasma testosterone levels.","volume":"257","author":"Kirkland","year":"1987","journal-title":"JAMA"},{"key":"2019041121494346000_R201","first-page":"1244","article-title":"Clinical trial of a non-injectable male contraceptive: transdermal testosterone and oral levonorgestrel.","volume":"84","author":"Bu\u0308chter","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R202","first-page":"561","article-title":"Metabolic and behavioral effects of high dose exogenous testosterone in healthy men.","volume":"79","author":"Bagatell","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0010-7824(95)00136-0","article-title":"Effects of testosterone enanthate on serum lipoproteins in man.","volume":"52","author":"Anderson","year":"1995","journal-title":"Contraception"},{"key":"2019041121494346000_R204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ijan.1995.18.5.237","article-title":"Testosterone enanthate at a dose of 200 mg\/week decreases HDL-cholesterol levels in healthy men.","volume":"18","author":"Meriggiola","year":"1995","journal-title":"Int J Androl"},{"key":"2019041121494346000_R205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0015-0282(16)58166-7","volume":"65","author":"Wu","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R206","first-page":"757","article-title":"Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.","volume":"81","author":"Bebb","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R207","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/j.1939-4640.1997.tb01913.x","article-title":"Progestin-androgen combination regimens for male contraception.","volume":"18","author":"Meriggiola","year":"1997","journal-title":"J Androl"},{"key":"2019041121494346000_R208","first-page":"112","article-title":"Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis and lipid metabolism.","volume":"84","author":"Wu","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R209","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.1939-4640.1999.tb02535.x","article-title":"A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.","volume":"20","author":"Anawalt","year":"1999","journal-title":"J Androl"},{"key":"2019041121494346000_R210","first-page":"303","article-title":"Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.","volume":"86","author":"Kamischke","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R211","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0029-7844(94)00448-M","article-title":"Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.","volume":"85","author":"Watts","year":"1995","journal-title":"Obstet Gynecol"},{"key":"2019041121494346000_R212","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2265.1998.00525.x","article-title":"The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women.","volume":"49","author":"Buckler","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R213","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-5122(94)00861-Z","article-title":"The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women.","volume":"21","author":"Goh","year":"1995","journal-title":"Maturitas"},{"key":"2019041121494346000_R214","first-page":"281","article-title":"Safety of estrogen\/androgen regimens.","volume":"46(Suppl 3)","author":"Simon","year":"2001","journal-title":"J Reprod Med"},{"key":"2019041121494346000_R215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0015-0282(01)01923-9","article-title":"Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries.","volume":"76","author":"Penotti","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R216","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-60-1-203","article-title":"Suppression of plasma testosterone leads to increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B.","volume":"60","author":"Goldberg","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R217","doi-asserted-by":"crossref","first-page":"967","DOI":"10.7326\/0003-4819-116-12-967","article-title":"Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.","volume":"116","author":"Bagatell","year":"1992","journal-title":"Ann Intern Med"},{"key":"2019041121494346000_R218","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1994.tb02475.x","article-title":"Sustained suppression of serum LH, FSH, and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men.","volume":"40","author":"Behre","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R219","first-page":"3367","article-title":"Suppression of endogenous testosterone in young men increases serum levels of HDL-subclass LpA-I and lipoprotein(a).","volume":"82","author":"von Eckardstein","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000475180","article-title":"Effects of the nonsteroidal androgen casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.","volume":"27","author":"Eri","year":"1995","journal-title":"Eur J Urol"},{"key":"2019041121494346000_R221","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(01)67239-2","article-title":"Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.","volume":"154","author":"Eri","year":"1995","journal-title":"J Urol"},{"key":"2019041121494346000_R222","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0021-9150(99)00442-6","article-title":"Changes in HDL-cholesterol and lipoprotein Lp(a) after 6-month treatment with finasteride in males affected by benign prostatic hyperplasia (BPH).","volume":"152","author":"Denti","year":"2000","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R223","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jcem-66-2-314","article-title":"Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.","volume":"66","author":"Moorjani","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R224","first-page":"855","article-title":"Physiological levels of estradiol stimulate plasma high density lipoprotein 2 cholesterol levels in normal men.","volume":"78","author":"Bagatell","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2265.1998.3721211.x","article-title":"Effects of testosterone replacement on HDL subfractions and apolipoprotein A-1 containing lipoproteins.","volume":"48","author":"Tan","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R226","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2265.1999.00882.x","article-title":"Alterations in hepatic lipase and lipoprotein subfractions with transdermal testosterone replacement therapy.","volume":"51","author":"Tan","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R227","first-page":"39","article-title":"Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.","volume":"22","author":"Santamarina-Fojo","year":"2000","journal-title":"Int J Tissue React"},{"key":"2019041121494346000_R228","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.0954-6820.1987.tb03357.x","article-title":"Increase in hepatic lipase activity after testosterone substitution in men with hypogonadism of pituitary origin.","volume":"221","author":"Valdemarsson","year":"1987","journal-title":"Acta Med Scand"},{"key":"2019041121494346000_R229","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9150(88)90014-7","article-title":"Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal men.","volume":"69","author":"Sorva","year":"1988","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R230","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2362.1989.tb00256.x","article-title":"The effect of testosterone replacement on plasma lipids and apolipoproteins.","volume":"19","author":"Jones","year":"1989","journal-title":"Eur J Clin Invest"},{"key":"2019041121494346000_R231","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.1989.03420080085036","article-title":"Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.","volume":"261","author":"Thompson","year":"1989","journal-title":"JAMA"},{"key":"2019041121494346000_R232","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0026-0495(99)90056-2","article-title":"Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men.","volume":"48","author":"Jockenho\u0308vel","year":"1999","journal-title":"Metabolism"},{"key":"2019041121494346000_R233","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0026-0495(90)90150-B","article-title":"High density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered.","volume":"39","author":"Friedl","year":"1990","journal-title":"Metabolism"},{"key":"2019041121494346000_R234","first-page":"123","article-title":"Influence of testosterone isobutyrate on serum lipoproteins during replacement therapy of hypogonadal men.","volume":"14","author":"Hana","year":"1991","journal-title":"Czech Med"},{"key":"2019041121494346000_R235","first-page":"1092","article-title":"Effects of testosterone supplementation in the aging male.","volume":"75","author":"Tenover","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R236","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0021-9150(95)05756-0","article-title":"Testosterone-induced suppression of lipoprotein(a) in normal men: relation to basal lipoprotein(a) level.","volume":"122","author":"Marcovina","year":"1996","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R237","first-page":"2670","article-title":"Effects of testosterone replacement in hypogonadal men.","volume":"85","author":"Snyder PJ Peachey","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R238","first-page":"69","article-title":"The effect of testosterone aromatization on high density lipoprotein cholesterol levels and post-heparin lipolytic activity.","volume":"39","author":"Zmuda","year":"1993","journal-title":"Metabolism"},{"key":"2019041121494346000_R239","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1532-5415.1993.tb02049.x","article-title":"Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study.","volume":"41","author":"Morley","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"2019041121494346000_R240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9150(95)05673-4","article-title":"Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.","volume":"121","author":"Zgliczynski","year":"1996","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R241","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/s-2007-978950","article-title":"Effect of testosterone replacement on whole body glucose utilization and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.","volume":"30","author":"Tripathy","year":"1998","journal-title":"Horm Metab Res"},{"key":"2019041121494346000_R242","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-133-5-200009050-00010","article-title":"Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.","volume":"133","author":"Grinspoon","year":"2000","journal-title":"Ann Intern Med"},{"key":"2019041121494346000_R243","doi-asserted-by":"crossref","first-page":"E1172","DOI":"10.1152\/ajpendo.2001.281.6.E1172","article-title":"Testosterone dose-response relationships in healthy young men.","volume":"281","author":"Bhasin","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121494346000_R244","first-page":"3567","article-title":"Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate\u2014a clinical research center study.","volume":"80","author":"Salehian","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1536\/ihj.38.73","article-title":"Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study.","volume":"38","author":"Uyanik","year":"1997","journal-title":"Jpn Heart J"},{"key":"2019041121494346000_R246","first-page":"75","article-title":"A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10\u201311 weeks in hypogonadal men.","volume":"74","author":"Bhasin","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R247","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9343(01)00813-0","article-title":"Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.","volume":"111","author":"Snyder","year":"2001","journal-title":"Am J Med"},{"key":"2019041121494346000_R248","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.2001.01297.x","article-title":"Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.","volume":"55","author":"Howell","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121494346000_R249","first-page":"1026","article-title":"Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.","volume":"86","author":"Dobs","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R250","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jcem.86.9.7821","article-title":"A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.","volume":"86","author":"Ly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R251","first-page":"205","article-title":"Some measures of lipid metabolism in young sterile men before and after testosterone treatment.","volume":"23","author":"Hromadova","year":"1989","journal-title":"Endocrinol Exp"},{"key":"2019041121494346000_R252","first-page":"3372","article-title":"Effects of gonadotropin and testosterone treatment on lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.","volume":"81","author":"Ozata","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R253","first-page":"3469","article-title":"Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men\u2014a clinical research center study.","volume":"81","author":"Brodsky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R254","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.","volume":"81","author":"Katznelson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R255","first-page":"3213","article-title":"Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism.","volume":"82","author":"Arslanian","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R256","first-page":"212","article-title":"[The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men.]","volume":"100","author":"Rabijewski","year":"1998","journal-title":"Pol Arch Med Wewn"},{"key":"2019041121494346000_R257","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9343(01)00833-6","article-title":"Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.","volume":"111","author":"Whitsel","year":"2001","journal-title":"Am J Med"},{"key":"2019041121494346000_R258","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0025-6196(19)30648-2","article-title":"Experience with testosterone replacement in the elderly.","volume":"75(Suppl)","author":"Tenover","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"2019041121494346000_R259","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0015-0282(16)58166-7","article-title":"Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility.","volume":"65","author":"Wu","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121494346000_R260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.21.1.13","article-title":"HDL and coronary heart disease: role of cholesterol efflux and reverse cholesterol transport.","volume":"20","author":"von Eckardstein","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R261","first-page":"627"},{"key":"2019041121494346000_R262","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.ATV.14.5.707","article-title":"Human HDL-cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL size.","volume":"14","author":"Brinton","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"2019041121494346000_R263","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-2275(20)41643-8","article-title":"In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice.","volume":"32","author":"Tang","year":"1991","journal-title":"J Lipid Res"},{"key":"2019041121494346000_R264","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.biochem.68.1.523","article-title":"Charting the fate of the \u201cgood cholesterol\u201d: identification and characterization of the high-density lipoprotein receptor SR-BI.","volume":"68","author":"Krieger","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"2019041121494346000_R264A","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0006-291X(02)02038-7","article-title":"Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages.","volume":"296","author":"Langer","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121494346000_R265","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0026-0495(76)90059-7","article-title":"Effect of sex hormones on protamine inactivated and resistant postheparin plasma lipase.","volume":"25","author":"Glueck","year":"1976","journal-title":"Metabolism"},{"key":"2019041121494346000_R266","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000183792","article-title":"Effects of sex steroids on hepatic and lipoprotein lipase activity and mRNA in the rat.","volume":"40","author":"Peinado-Onsurbe","year":"1993","journal-title":"Horm Res"},{"key":"2019041121494346000_R267","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041433-199906000-00005","article-title":"Lipoprotein(a): intrigues and insights.","volume":"10","author":"Hobbs","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R268","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archinte.1997.00440320040005","article-title":"Lipoprotein Lp(a) excess and coronary heart disease.","volume":"157","author":"Stein","year":"1997","journal-title":"Arch Intern Med"},{"key":"2019041121494346000_R269","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/S0735-1097(00)01126-8","article-title":"Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.","volume":"37","author":"von Eckardstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2019041121494346000_R270","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.CIR.100.7.743","article-title":"Increased lipoprotein (a) is an important risk factor for thromboembolism in childhood.","volume":"100","author":"Nowak-Go\u0308ttl","year":"1999","journal-title":"Circulation"},{"key":"2019041121494346000_R271","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-0037-1613815","article-title":"Evaluation of lipoprotein(a) and genetic prothrombotic risk factors in patients with recurrent foetal loss.","volume":"83","author":"Nowak-Go\u0308ttl","year":"2000","journal-title":"Thromb Haemost"},{"key":"2019041121494346000_R272","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood.V97.4.858","article-title":"Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.","volume":"97","author":"Nowak-Go\u0308ttl","year":"2001","journal-title":"Blood"},{"key":"2019041121494346000_R273","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041433-199712000-00003","article-title":"Therapy for lowering lipoprotein(a) levels.","volume":"8","author":"Angelin","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R274","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00041433-199405030-00012","article-title":"Sex hormones and lipoprotein metabolism.","volume":"5","author":"Sacks","year":"1994","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R275","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI115699","article-title":"Hormonal regulation of serum Lp(a) levels.","volume":"89","author":"Henriksson","year":"1992","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R276","first-page":"2633","article-title":"Hormonal regulation of serum lipoprotein(a) levels: effects of parenteral administration of estrogen or testosterone in males.","volume":"81","author":"Berglund","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R277","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0002-9149(96)00174-9","article-title":"Testosterone decreases lipoprotein(a) in men.","volume":"77","author":"Zmuda","year":"1996","journal-title":"Am J Cardiol"},{"key":"2019041121494346000_R278","first-page":"2508","article-title":"Treatment of prostate cancer with gonadotropin releasing hormone analogue: effect on lipoprotein(a).","volume":"81","author":"Arrer","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R279","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/clinchem\/42.8.1176","article-title":"Effects of androgen suppression by gonadotropin-releasing hormone agonist and flutamide on lipid metabolism in men with prostate cancer: focus on lipoprotein(a).","volume":"42","author":"Denti","year":"1996","journal-title":"Clin Chem"},{"key":"2019041121494346000_R280","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng0495-424","article-title":"The apolipoprotein(a) gene is regulated by sex hormones and acute phase inducers in YAC transgenic mice.","volume":"9","author":"Frazer","year":"1995","journal-title":"Nat Genet"},{"key":"2019041121494346000_R281","first-page":"3267","article-title":"Metabolism of apo(a) and apoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement.","volume":"83","author":"Su","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R282","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.283.14.1845","article-title":"Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause","volume":"283","author":"Shlipak","year":"2000","journal-title":"JAMA."},{"key":"2019041121494346000_R283","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-130-11-199906010-00018","article-title":"Evaluating novel cardiovascular risk factors: can we better predict heart attacks?","volume":"130","author":"Ridker","year":"1999","journal-title":"Ann Intern Med"},{"key":"2019041121494346000_R284","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0038-1649799","article-title":"Haemostatic effects of supraphysiological levels of testosterone in normal men.","volume":"74","author":"Anderson","year":"1995","journal-title":"Thromb Haemost"},{"key":"2019041121494346000_R285","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0038-1661110","article-title":"Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.","volume":"51","author":"Verheijen","year":"1984","journal-title":"Thromb Haemost"},{"key":"2019041121494346000_R286","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jcem.82.6.3995","article-title":"Tibolone: influence on markers of cardiovascular disease.","volume":"82","author":"Bjarnasson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R287","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/13621807990050S108","article-title":"Tibolone and the risk of arterial disease","volume":"S1","author":"Crook","year":"1999","journal-title":"J Br Menopause Soc"},{"key":"2019041121494346000_R288","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-5122(96)82004-4","article-title":"Effects of androgens on haemostasis.","volume":"24","author":"Winkler","year":"1996","journal-title":"Maturitas"},{"key":"2019041121494346000_R289","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-9378(95)90344-5","article-title":"The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones.","volume":"173","author":"Sobel","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121494346000_R290","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0038-1653405","article-title":"Testosterone potentiation of ionophere and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.","volume":"46","author":"Pilo","year":"1981","journal-title":"Thromb Haemost"},{"key":"2019041121494346000_R291","first-page":"205","author":"The International Task Force for the Prevention of Coronary Heart Dsease","year":"1998"},{"key":"2019041121494346000_R292","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of The National Cholesterol Education Program (NCEP).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"2019041121494346000_R293","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis: the road ahead.","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"2019041121494346000_R294","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R295","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI118967","article-title":"Adhesion and signaling in vascular cell-cell interactions.","volume":"98","author":"Zimmerman","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R296","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF03044351","article-title":"Sex hormones and vascular reactivity.","volume":"22","author":"Hutchison","year":"1997","journal-title":"Herz"},{"key":"2019041121494346000_R297","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00041433-199710000-00007","article-title":"Effects of estrogens on macrophage foam cells: a potential target for the protective effects of estrogens on atherosclerosis.","volume":"8","author":"St Clair","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R298","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI110513","article-title":"Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids.","volume":"69","author":"Horwitz","year":"1982","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R299","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.CIR.103.10.1382","article-title":"Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall.","volume":"103","author":"Hanke","year":"2001","journal-title":"Circulation"},{"key":"2019041121494346000_R300","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0960-0760(94)90025-6","article-title":"Androgen receptors, 5\u03b1 reductase activity and androgen-dependent proliferation of vascular smooth muscle cells.","volume":"50","author":"Fujimoto","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121494346000_R301","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1749-6632.1996.tb16277.x","article-title":"Primary cultures of human synovial macrophages metabolize androgens.","volume":"784","author":"Cutolo","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R302","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V95.7.2289","article-title":"Human megakaryocytes and platelets contain the estrogen receptor \u03b2 and androgen receptor (AR): testosterone regulates AR expression.","volume":"95","author":"Khetawat","year":"2000","journal-title":"Blood"},{"key":"2019041121494346000_R303","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.RES.84.11.1285","article-title":"Localized expression of aromatase in human vascular tissue.","volume":"84","author":"Harada","year":"1999","journal-title":"Circ Res"},{"key":"2019041121494346000_R304","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00042192-199906010-00006","article-title":"Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects.","volume":"6","author":"Diano","year":"1999","journal-title":"Menopause"},{"key":"2019041121494346000_R305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1507\/endocrj.46.233","article-title":"Aromatase and sex steroid receptors in human vena cava.","volume":"46","author":"Sasano","year":"1999","journal-title":"Endocr J"},{"key":"2019041121494346000_R306","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/joe.0.1640161","article-title":"Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages.","volume":"164","author":"Schmidt","year":"2000","journal-title":"J Endocrinol"},{"key":"2019041121494346000_R307","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1210\/jcem-23-3-306","article-title":"Vascular and extravascular radioactivity after injection of estradiol-6,7 H3 in the human being. J Clin.","volume":"23","author":"Malinow","year":"1963","journal-title":"Endocrinol Metab"},{"key":"2019041121494346000_R308","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0021-9150(81)90105-2","article-title":"Estradiol-binding sites in rat aortic smooth muscle cells in culture.","volume":"38","author":"Nakao","year":"1981","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R309","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.89.5.1943","article-title":"Human vascular smooth muscle cells contain functional estrogen receptor.","volume":"89","author":"Karas","year":"1994","journal-title":"Circulation"},{"key":"2019041121494346000_R310","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.CIR.89.4.1501","article-title":"Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.","volume":"89","author":"Losordo","year":"1994","journal-title":"Circulation"},{"key":"2019041121494346000_R311","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1210\/endo.136.4.7895662","article-title":"Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture.","volume":"136","author":"Bayard","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121494346000_R312","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.CIR.94.4.727","article-title":"Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function.","volume":"94","author":"Venkov","year":"1996","journal-title":"Circulation"},{"key":"2019041121494346000_R313","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0897.1995.tb00965.x","article-title":"Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes.","volume":"34","author":"Ben-Hur","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"2019041121494346000_R314","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogens on the cardiovascular system.","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R315","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/01.CIR.94.6.1402","article-title":"Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells.","volume":"94","author":"Kim-Schulze","year":"1996","journal-title":"Circulation"},{"key":"2019041121494346000_R316","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1161\/01.CIR.101.15.1792","article-title":"Estrogen receptors \u03b1 and \u03b2: prevalence of estrogen receptor \u03b2 mRNA in human vascular smooth muscle and transcriptional effects.","volume":"101","author":"Hodges","year":"2000","journal-title":"Circulation"},{"key":"2019041121494346000_R317","first-page":"307","article-title":"Cell membrane and nuclear receptors derive from a single transcript: studies of ER\u03b1 and ER\u03b2 expressed in CHO cells.","volume":"13","author":"Razandi","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041121494346000_R318","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.HYP.34.6.1232","article-title":"Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats.","volume":"34","author":"Honda","year":"1999","journal-title":"Hypertension"},{"key":"2019041121494346000_R319","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1096\/fasebj.13.1.123","article-title":"Functional testosterone receptors in plasma membranes of T cells.","volume":"13","author":"Benten","year":"1999","journal-title":"FASEB J"},{"key":"2019041121494346000_R320","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0960-0760(94)00160-N","article-title":"Emerging diversities in the mechanism of action of steroid hormones.","volume":"52","author":"Brann","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121494346000_R321","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.RES.48.2.238","article-title":"Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon.","volume":"48","author":"McGill","year":"1981","journal-title":"Circ Res"},{"key":"2019041121494346000_R322","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1016\/S0021-9258(17)37270-8","article-title":"Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein.","volume":"269","author":"Lieberherr","year":"1994","journal-title":"J Biol Chem"},{"key":"2019041121494346000_R323","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041433-200002000-00003","article-title":"Endothelial dysfunctions: common denominators in vascular disease.","volume":"11","author":"De Caterina","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R324","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1096\/fasebj.10.2.8641561","article-title":"Endothelial control of the cardiovascular system: recent advances.","volume":"10","author":"Griedling","year":"1996","journal-title":"FASEB J"},{"key":"2019041121494346000_R325","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","article-title":"Mechanisms lead to myocardial infarction: insights from studies in vascular biology.","volume":"90","author":"Fuster","year":"1994","journal-title":"Circulation"},{"key":"2019041121494346000_R326","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes.","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"2019041121494346000_R327","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00004872-200018100-00003","article-title":"Chronic and acute effects of oestrogens on vascular contractility.","volume":"18","author":"Austin","year":"2000","journal-title":"J Hypertens"},{"key":"2019041121494346000_R328","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0146-0005(00)80060-9","article-title":"Novel role of estrogen receptors in vascular endothelium.","volume":"24","author":"Shaul","year":"2000","journal-title":"Semin Perinatol"},{"key":"2019041121494346000_R329","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jcem.84.10.5954","article-title":"Cardiovascular actions of estrogens in men.","volume":"84","author":"Sudhir","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.pharmtox.37.1.477","article-title":"Estrogens and atherosclerosis.","volume":"37","author":"Nathan","year":"1997","journal-title":"Annu Rev Pharamcol Toxicol"},{"key":"2019041121494346000_R331","first-page":"739","article-title":"Estrogen, progesterone and vascular reactivity: potential cellular mechanisms.","volume":"16","author":"White","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041121494346000_R332","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0735-1097(97)00063-6","article-title":"Arterial reactivity is enhanced in genetic males taking high dose estrogens.","volume":"29","author":"McCrohon","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2019041121494346000_R333","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0735-1097(97)00080-6","article-title":"Long-term estrogen therapy improves vascular function in male to female transsexuals.","volume":"29","author":"New","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2019041121494346000_R334","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0735-1097(98)00416-1","article-title":"Vascular reactivity is impaired in genetic females taking high-dose androgens.","volume":"32","author":"McCredie","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2019041121494346000_R335","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.ATV.17.10.2004","article-title":"Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men.","volume":"17","author":"Herman","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R336","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1210\/jcem.86.10.7889","article-title":"The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity.","volume":"86","author":"Zitzmann","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R337","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9149(99)00630-X","article-title":"Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease.","volume":"85","author":"Ong","year":"2000","journal-title":"Am J Cardiol"},{"key":"2019041121494346000_R338","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1210\/jcem.86.1.7103","article-title":"Evidence that parenteral testosterone therapy may improve endothelium-dependent and independent vasodilatation in postmenopausal women already receiving estrogen.","volume":"88","author":"Worboys","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R339","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.CIR.94.10.2614","article-title":"Testosterone induces dilatation of canine coronary conductance and resistance arteries in vivo.","volume":"94","author":"Chou","year":"1996","journal-title":"Circulation"},{"key":"2019041121494346000_R340","first-page":"34","article-title":"Testosterone causes direct relaxation of rat thoracic aorta.","volume":"277","author":"Costarella","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041121494346000_R341","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00005344-199503000-00023","article-title":"Effect of testosterone treatment on vasoconstrictor response of left anterior descend coronary artery in male and female pigs.","volume":"25","author":"Farhat","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"2019041121494346000_R342","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.91.4.1154","article-title":"Testosterone relaxes rabbit coronary arteries and aorta.","volume":"91","author":"Yue","year":"1995","journal-title":"Circulation"},{"key":"2019041121494346000_R343","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/sj.bjp.0703164","article-title":"Differential effects of 17\u03b2-estradiol and testosterone on the contractile responses of porcine coronary arteries.","volume":"129","author":"Teoh","year":"2000","journal-title":"Br J Pharmacol"},{"key":"2019041121494346000_R344","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1440-1681.1999.03138.x","article-title":"Acute exposure to a low level of testosterone impairs relaxation in porcine coronary arteries.","volume":"26","author":"Quan","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2019041121494346000_R345","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00005344-199905000-00003","article-title":"Acute and nongenomic effects of testosterone on isolated and perfused rat heart.","volume":"33","author":"Ceballos","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"2019041121494346000_R346","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0735-1097(96)00570-0","article-title":"Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta.","volume":"29","author":"Hutchison","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2019041121494346000_R347","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.2000.279.2.H610","article-title":"Gonadal hormones affect diameter of male rat cerebral arteries through endothelium-dependent mechanisms.","volume":"279","author":"Geary","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041121494346000_R348","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-5793(95)00124-R","article-title":"Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells.","volume":"360","author":"Hishikawa","year":"1995","journal-title":"FEBS Lett"},{"key":"2019041121494346000_R349","first-page":"44","article-title":"Decreased [Ca2+]i during inhibition of coronary smooth muscle contraction by 17\u03b2-estradiol, progesterone, and testosterone.","volume":"291","author":"Murphy","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041121494346000_R350","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.69.3.638","article-title":"Testosterone increases thromboxane A2 receptors in cultured rat smooth muscle cells.","volume":"69","author":"Masuda","year":"1995","journal-title":"Circ Res"},{"key":"2019041121494346000_R351","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-8703(97)70227-8","article-title":"Long-term estrogen therapy abolishes acute estrogen-induced coronary flow augmentation in postmenopausal women.","volume":"133","author":"Blumenthal","year":"1997","journal-title":"Am Heart J"},{"key":"2019041121494346000_R352","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1053\/euhj.1998.0975","article-title":"Does sublingual 17\u03b2-oestradiol have any effects on exercise capacity and myocardial ischaemia in post-menopausal women with stable coronary artery disease?","volume":"19","author":"Al-Khalili","year":"1998","journal-title":"Eur Heart J"},{"key":"2019041121494346000_R353","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0002-9149(98)00293-8","article-title":"Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women.","volume":"82","author":"Anderson","year":"1998","journal-title":"Am J Cardiol"},{"key":"2019041121494346000_R354","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.ATV.20.2.290","article-title":"Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis.","volume":"20","author":"de Winther","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R355","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00041433-200010000-00005","article-title":"Metabolism of oxidized LDL by macrophages.","volume":"11","author":"Jessup","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"2019041121494346000_R356","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1388-1981(00)00146-3","article-title":"Cholesterol and phospholipid metabolism in macrophages.","volume":"1529","author":"Tabas","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"2019041121494346000_R357","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9378(97)70462-9","article-title":"17\u03b2-Estradiol, progesterone, and testosterone inversely modulate low density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages.","volume":"177","author":"Zhu","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121494346000_R358","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0005-2760(94)90018-3","article-title":"Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroids.","volume":"1213","author":"Aikawa","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"2019041121494346000_R359","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0005-2760(96)00009-4","article-title":"Inhibiion of cholesteryl ester accumulation by 17\u03b2-estradiol in macrophages through activation of neutral cholesterol esterase.","volume":"1300","author":"Tomita","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"2019041121494346000_R360","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.1074\/jbc.273.14.8434","article-title":"In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells.","volume":"273","author":"Fluiter","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041121494346000_R361","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/j.1939-4640.1996.tb00585.x","article-title":"Secretion of bioactive interleukin 1 by rat testicular macrophages in vitro.","volume":"17","author":"Hayes","year":"1996","journal-title":"J Androl"},{"key":"2019041121494346000_R362","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1507\/endocrj.43.151","article-title":"Changes in interleukin 1 production of peritoneal macrophages during estrous cycle in golden hamsters.","volume":"43","author":"Yoshida","year":"1996","journal-title":"Endocrine J"},{"key":"2019041121494346000_R363","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1749-6632.1999.tb07667.x","article-title":"Sex hormones modulate inflammatory mediators produced by macrophages.","volume":"876","author":"D\u2019Agostino","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R364","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/physrev.1995.75.3.487","article-title":"Regulation and differentiation of vascular smooth muscle cells.","volume":"75","author":"Owens","year":"1995","journal-title":"Physiol Rev"},{"key":"2019041121494346000_R365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(96)06023-6","article-title":"Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells.","volume":"130","author":"Akishita","year":"1997","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R366","first-page":"969","article-title":"Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.","volume":"148","author":"Kolodgie","year":"1996","journal-title":"Am J Pathol"},{"key":"2019041121494346000_R367","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"key":"2019041121494346000_R368","first-page":"E928","article-title":"Androgen regulation of thromboxane A2\/prostaglandin H2 receptor expression in human erythroleukemia cells.","volume":"265","author":"Matsuda","year":"1993","journal-title":"Am J Physiol"},{"key":"2019041121494346000_R369","first-page":"H887","article-title":"Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets.","volume":"267","author":"Matsuda","year":"1994","journal-title":"Am J Physiol"},{"key":"2019041121494346000_R370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1749-6632.1995.tb17376.x","article-title":"Dehydroepiandrosterone sulfate and ageing.","volume":"774","author":"Vermeulen","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R371","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1749-6632.1994.tb56858.x","article-title":"Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.","volume":"719","author":"Birkenhager-Gillesse","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R372","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/oxfordjournals.epirev.a036071","article-title":"Dehydroepiandrosterone and Dehydroepiandrosterone sulfate: their relation to cardiovascular disease.","volume":"13","author":"Nafziger","year":"1991","journal-title":"Epidemiol Rev"},{"key":"2019041121494346000_R373","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(94)92587-9","article-title":"Physiological importance of dehydroepiandrosterone.","volume":"343","author":"Ebeling","year":"1994","journal-title":"Lancet"},{"key":"2019041121494346000_R374","first-page":"S149","article-title":"Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.","volume":"150(Suppl)","author":"Khaw","year":"1996","journal-title":"J Endocrinol"},{"key":"2019041121494346000_R375","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0039-128X(98)00007-5","article-title":"DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.","volume":"63","author":"Labrie","year":"1998","journal-title":"Steroids"},{"key":"2019041121494346000_R376","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/000331975901000504","article-title":"17-Ketosteroids and arteriosclerosis.","volume":"10","author":"Kask","year":"1959","journal-title":"Angiology"},{"key":"2019041121494346000_R377","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJM198612113152405","article-title":"A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.","volume":"315","author":"Barrett-Connor","year":"1986","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R378","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0735-1097(10)80334-1","article-title":"Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography.","volume":"16","author":"Herrington","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"2019041121494346000_R379","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.CIR.86.5.1529","article-title":"Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men.","volume":"86","author":"LaCroix","year":"1992","journal-title":"Circulation"},{"key":"2019041121494346000_R380","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000175022","article-title":"Role of adrenal androgens in the development of arteriosclerosis as judged by pulse wave velocity and calcification of the aorta.","volume":"80","author":"Ishihara","year":"1992","journal-title":"Cardiology"},{"key":"2019041121494346000_R381","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1995.tb17387.x-i1","article-title":"Dehydroepiandrosterone and coronary atherosclerosis.","volume":"774","author":"Herrington","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R382","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1749-6632.1995.tb17386.x-i1","article-title":"The epidemiology of DHEAS and cardiovascular disease.","volume":"774","author":"Barrett-Connor","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R383","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/oxfordjournals.aje.a117175","article-title":"Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study.","volume":"140","author":"Newcomer","year":"1994","journal-title":"Am J Epidemiol"},{"key":"2019041121494346000_R384","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1073\/pnas.93.23.13410","article-title":"Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological and mental status and short-term mortality: a French community-based study.","volume":"93","author":"Berr","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121494346000_R385","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/hrt.80.4.334","article-title":"von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.","volume":"80","author":"Jansson","year":"1998","journal-title":"Heart"},{"key":"2019041121494346000_R386","first-page":"30","article-title":"Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population.","volume":"11","author":"Tilvis","year":"1999","journal-title":"Aging (Milano)"},{"key":"2019041121494346000_R387","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.20.4.1094","article-title":"No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study).","volume":"20","author":"Kiechl","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R388","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1210\/jcem.86.9.7838","article-title":"Dehydroepiandrosterone sulfate and mortality in elderly men and women.","volume":"86","author":"Trevedi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R389","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJM198709103171115","article-title":"Absence of an inverse relation of dehydroepiandrosteroneysulfate with cardiovascular mortality in postmenopausal women.","volume":"317","author":"Barrett-Connor","year":"1987","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R390","first-page":"1834","article-title":"The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity.","volume":"85","author":"Moriyama","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R391","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.91.6.1757","article-title":"Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women.","volume":"15","author":"Barrett-Connor","year":"1995","journal-title":"Circulation"},{"key":"2019041121494346000_R392","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2796.1995.tb00871.x","article-title":"Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease.","volume":"237","author":"Slowinska-Srzednicka","year":"1995","journal-title":"J Intern Med"},{"key":"2019041121494346000_R393","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jcem-66-1-57","article-title":"Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.","volume":"66","author":"Nestler","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R394","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.","volume":"78","author":"Morales","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R395","doi-asserted-by":"crossref","first-page":"M1","DOI":"10.1093\/gerona\/52A.1.M1","article-title":"Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men","volume":"52","author":"Khoram","year":"1997","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2019041121494346000_R396","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0950-351X(98)80286-3","article-title":"Is there a case for DHEA replacement?","volume":"12","author":"Nippoldt","year":"1998","journal-title":"Bailliere\u2019s Clin Endocrinol Metab"},{"key":"2019041121494346000_R397","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/jcem.83.6.4850","article-title":"Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.","volume":"83","author":"Arlt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R398","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency.","volume":"341","author":"Arlt","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R399","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0165-0173(99)00021-1","article-title":"Actions of dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) in the central nervous system (CNS): effects on cognition and emotion in animals and humans.","volume":"30","author":"Wolf","year":"1999","journal-title":"Brain Res"},{"key":"2019041121494346000_R400","first-page":"3208","article-title":"Dehyroepiandrosterone replacement administration: pharmacokinetic and phsrmacodynamic studies in healthy elderly subjects.","volume":"85","author":"Legrain","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R401","first-page":"4650","article-title":"Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison\u2019s disease in a randomized, double blind trial.","volume":"85","author":"Hunt","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R402"},{"key":"2019041121494346000_R403","first-page":"1527","article-title":"Dehydroepiandrosterone replacement in aging human.","volume":"84","author":"Flynn","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R404","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1210\/jcem.86.10.7974","article-title":"Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion.","volume":"86","author":"Arlt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R405","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI113652","article-title":"Reduction of atherosclerosis by administration of dehydroepiandrosterone: a study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.","volume":"82","author":"Gordon","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R406","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.ATV.9.2.159","article-title":"Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbits.","volume":"9","author":"Arad","year":"1989","journal-title":"Arteriosclerosis"},{"key":"2019041121494346000_R407","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.CIR.87.1.261","article-title":"Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation.","volume":"87","author":"Eich","year":"1993","journal-title":"Circulation"},{"key":"2019041121494346000_R408","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.ATV.20.3.782","article-title":"Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide.","volume":"20","author":"Hayashi","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121494346000_R409","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9629(15)41696-9","article-title":"Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men.","volume":"311","author":"Beer","year":"1996","journal-title":"Am J Med Sci"},{"key":"2019041121494346000_R410","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1749-6632.1995.tb17388.x-i1","article-title":"Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo.","volume":"774","author":"Jesse","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"2019041121494346000_R411","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0021-9150(96)05902-3","article-title":"Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774\u20131 cells.","volume":"126","author":"Taniguchi","year":"1996","journal-title":"Atherosclerosis"},{"key":"2019041121494346000_R412","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0925-4439(97)00085-9","article-title":"Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate.","volume":"1406","author":"Furutama","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"2019041121494346000_R413","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-5728(97)00244-0","article-title":"Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol and androstenetriol.","volume":"84","author":"Padgett","year":"1998","journal-title":"J Neuroimmunol"},{"key":"2019041121494346000_R414","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/jcem.83.6.4876","article-title":"Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum Interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in-vitro: possible link between endocrinosenescence and immunosenescence.","volume":"83","author":"Straub","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R415","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1128\/AAC.36.10.2275","article-title":"Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production.","volume":"36","author":"Danenberg","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041121494346000_R416","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1210\/endo.139.7.6118","article-title":"Dehydroapiandrosterone decreases serum tumor necrosis factor \u03b1 and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.","volume":"129","author":"Kimura","year":"1998","journal-title":"Endocrinology"},{"key":"2019041121494346000_R417","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R418","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and oestradiol in a man with aromatase deficiency.","volume":"337","author":"Carani","year":"1997","journal-title":"New Engl J Med"},{"key":"2019041121494346000_R419","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041121494346000_R420","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1161\/01.CIR.96.10.3774","article-title":"Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man.","volume":"96","author":"Sudhir","year":"1997","journal-title":"Circulation"},{"key":"2019041121494346000_R421","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(05)63022-X","article-title":"Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene.","volume":"349","author":"Sudhir","year":"1997","journal-title":"Lancet"},{"key":"2019041121494346000_R422","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1006\/bbrc.2000.3827","article-title":"Obesity and disturbed lipoprotein profile in estrogen receptor-\u03b1-deficient male mice.","volume":"278","author":"Ohlsson","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121494346000_R423","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI9575","article-title":"Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.","volume":"105","author":"Nemoto","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R424","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-\u03b1 knockout mice.","volume":"97","author":"Heine","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121494346000_R425","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1172\/JCI119426","article-title":"Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta.","volume":"99","author":"Rubanyi","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041121494346000_R426","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1677\/joe.0.166R005","article-title":"Increased magnitude of relaxation to oestrogen in aorta from oestrogen receptor \u03b2 knock-out mice.","volume":"166","author":"Nilsson","year":"2000","journal-title":"J Endocrinol"},{"key":"2019041121494346000_R427","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2014a common finding in normal women.","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"2019041121494346000_R428","first-page":"3078","article-title":"Prevalence of polycystic ovarian syndrome in unselected black and white women of the southeastern United States: a prospective study.","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121494346000_R429","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1067\/mob.2000.107627","article-title":"Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.","volume":"183","author":"Barbieri","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121494346000_R430","year":"2000"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/24\/2\/183\/8860900\/edrv0183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:30:03Z","timestamp":1704825003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/24\/2\/183\/2424255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":432,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2003,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2001-0025","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]}}}